Prestige Biopharma's Herceptin Biosimilar Tuznue® Receives Positive CHMP Opinion from the EMA

Prestige Biopharma Limited Singapore United Kingdom United States of America

Following approval by the European Commission, Prestige Biopharma's Herceptin biosimilar Tuznue® would become the first biosimilar from a Singaporean company to be authorized in the European Union.View original content:https://www.prnewswire.co.uk/news-releases/prestige-biopharmas-herceptin-biosimilar-tuznue-receives-positive-chmp-opinion-from-the-ema-302211174.html